Trial Profile
Phase I Trial of the Effects of LCI699 (Osilodrostat) on Cytochrome P450 Enzymes in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Feb 2017
Price :
$35
*
At a glance
- Drugs Osilodrostat (Primary)
- Indications Cushing syndrome
- Focus Pharmacokinetics
- Sponsors Novartis Pharmaceuticals Corporation
- 02 Feb 2017 Results published in the Clinical Drug Investigation
- 11 Aug 2015 New trial record